These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 18848851)

  • 1. Intracerebroventricular infusion of neuropeptide Y increases glucose dependent-insulinotropic peptide secretion in the fasting conscious dog.
    Yavropoulou MP; Kotsa K; Kesisoglou I; Anastasiou O; Yovos JG
    Peptides; 2008 Dec; 29(12):2281-5. PubMed ID: 18848851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular infusion of neuropeptide Y modulates VIP secretion in the fasting conscious dog.
    Anastasiou OE; Yavropoulou MP; Kesisoglou I; Kotsa K; Yovos JG
    Neuropeptides; 2009 Feb; 43(1):41-6. PubMed ID: 19058848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular infusion of bombesin modulates GIP secretion in conscious dogs.
    Yavropoulou MP; Kotsa K; Anastasiou OE; O'Dorisio TM; Pappas TN; Yovos JG
    Neuropharmacology; 2010 Jan; 58(1):226-32. PubMed ID: 19576914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intracerebroventricular infusion of insulin on glucose-dependent insulinotropic peptide in dogs.
    Yavropoulou MP; Kotsa K; Anastasiou O; O'Dorisio TM; Pappas TN; Yovos JG
    Neurosci Lett; 2009 Aug; 460(2):148-51. PubMed ID: 19477229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intracerebroventricular infusion of neurotensin in glucose-dependent insulinotropic peptide secretion in dogs.
    Yavropoulou MP; Kotsa K; Kesisoglou I; Gotzamani-Psarakou A; Yovos JG
    Peptides; 2010 Jan; 31(1):150-4. PubMed ID: 19799951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans.
    Meier JJ; Goetze O; Anstipp J; Hagemann D; Holst JJ; Schmidt WE; Gallwitz B; Nauck MA
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E621-5. PubMed ID: 14678954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
    Carr RD; Larsen MO; Winzell MS; Jelic K; Lindgren O; Deacon CF; Ahrén B
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E779-84. PubMed ID: 18612044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.
    Knop FK; Vilsbøll T; Højberg PV; Larsen S; Madsbad S; Holst JJ; Krarup T
    Regul Pept; 2007 Dec; 144(1-3):123-30. PubMed ID: 17692937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intracerebroventricular infusion of somatostatin-14 on peripheral glucoregulation in dogs.
    Yavropoulou MP; Kotsa K; Pikilidou M; Keisisoglou I; Yovos JG
    J Neuroendocrinol; 2014 Jan; 26(1):11-7. PubMed ID: 24325321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular injection of proinsulin C-peptide does not influence food consumption in male Long-Evans rats.
    Beck B
    Horm Metab Res; 2006 May; 38(5):314-6. PubMed ID: 16718627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of peripheral administration of synthetic human glucose-dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes.
    Daousi C; Wilding JP; Aditya S; Durham BH; Cleator J; Pinkney JH; Ranganath LR
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):195-201. PubMed ID: 19178509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebroventricular neuropeptide Y increases gastric and pancreatic secretion in the dog.
    Geoghegan JG; Lawson DC; Cheng CA; Opara E; Taylor IL; Pappas TN
    Gastroenterology; 1993 Oct; 105(4):1069-77. PubMed ID: 8405851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin attenuates the acute effects of centrally administered neuropeptide Y on somatotropin but not gonadotropin secretion in ovariectomized cows.
    Garcia MR; Amstalden M; Keisler DH; Raver N; Gertler A; Williams GL
    Domest Anim Endocrinol; 2004 Apr; 26(3):189-200. PubMed ID: 15036374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP).
    McIntosh CH; Widenmaier S; Kim SJ
    Vitam Horm; 2009; 80():409-71. PubMed ID: 19251046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats.
    Sainsbury A; Rohner-Jeanrenaud F; Grouzmann E; Jeanrenaud B
    Neuroendocrinology; 1996 Apr; 63(4):318-26. PubMed ID: 8739887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat.
    Marks JL; Waite K
    J Neuroendocrinol; 1997 Feb; 9(2):99-103. PubMed ID: 9041362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of gastric inhibitory peptide following a peptone meal in the dog.
    Wolfe MM; McGuigan JE
    Gastroenterology; 1982 Oct; 83(4):864-72. PubMed ID: 7049826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of fasting and neuropeptide Y on the suppressive food intake induced by intracerebroventricular injection of glucagon-like peptide-1 in the neonatal chick.
    Furuse M; Matsumoto M; Mori R; Sugahara K; Kano K; Hasegawa S
    Brain Res; 1997 Aug; 764(1-2):289-92. PubMed ID: 9295227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.